A randomized, controlled clinical trial comparing remimazolam to propofol when combined with alfentanil for sedation during ERCP procedures

In many countries, the combination of propofol and opioid is used as the preferred sedative regime during ERCP. However, the most serious risks of propofol sedation are oxygen deficiency and hypotension. Compared to midazolam, remimazolam has a faster onset and offset of hypnotic effect, as well as...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of clinical anesthesia Ročník 86; s. 111077
Hlavní autoři:	Dong, Shu-An, Guo, Yan, Liu, Sha-Sha, Wu, Li-Li, Wu, Li-Na, Song, Kai, Wang, Jing-Hua, Chen, Hui-Rong, Li, Wei-Zhi, Li, Huan-Xi, Zhang, Li, Yu, Jian-Bo
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 01.06.2023 Elsevier Limited
Témata:	Abdomen Alfentanil - adverse effects Anesthesia Blood pressure Cholangiopancreatography, Endoscopic Retrograde - adverse effects Chronic illnesses Conscious Sedation - adverse effects Conscious Sedation - methods Delirium Drug dosages Endoscopy ERCP General anesthesia Heart rate Humans Hypertension Hypnotics and Sedatives - adverse effects Hypotension Hypotension - chemically induced Hypotension - epidemiology Hypoxia Hypoxia - chemically induced Hypoxia - epidemiology Nausea Oxygen saturation Pain Medicine Patients Pharmaceuticals Postoperative period Propofol Propofol - adverse effects Remimazolam Safety Remimazolam ERCP Safety Propofol
ISSN:	0952-8180, 1873-4529, 1873-4529
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!